SHANGHAI, Nov. 7 (Xinhua) — During the 8th China International Import Expo (CIIE), Australian health supplement leader Homart Group signed a strategic cooperation agreement and a Memorandum of Understanding (MOU) with JD Health and AliExpress, witnessed by the Hon Don Farrell, Australian Minister for Trade and Tourism, and other government officials. The partnerships mark another milestone in Homart’s expansion into China’s thriving health market and its commitment to global integration.

At the expo, Homart and JD Health formalized a long-term strategic partnership focusing on flagship store operations, new product incubation, consumer education, and anti-counterfeiting traceability. The collaboration aims to strengthen brand building and service upgrades for Australian health products in China.

From left to right: Mr. John Madew, Senior Trade and Investment Commissioner and Deputy Consul-General; Ms. Lynn Yeh, CEO, Homart Group; the Hon Don Farrell, Australian Minister for Trade and Tourism; Ms. Changyue Song, Head of Cross-Border Business, JD Health; and Dr. Paul Grimes, CEO, Austrade.

From left to right: Ms. Lynn Yeh, CEO, Homart Group; Mr. Martin Ferreyra, Representative, Austrade; and Mr. Haohang Song, Vice President and General Manager of Nutrition and Health, JD Health.

In the presence of the Hon Don Farrell and Dr. Paul Grimes, CEO of Austrade, the strategic cooperation agreement was signed by Lynn Yeh, CEO of Homart Group, and Changyue Song, Head of Cross-border Business, JD Health. Lynn Yeh, Haohang Song, Vice President and General Manager of Nutrition and Health at JD Health, and Martin Ferreyra from Austrade jointly participated in the ribbon-cutting ceremony.

As Homart deepens its presence in China, it is also accelerating its global expansion. During the CIIE, Homart signed a strategic MOU with AliExpress, Alibaba Group’s international e-commerce platform, to strengthen collaboration in cross-border e-commerce, global marketing, and digital retail. The partnership aims to bring high-quality Australian-made health products to global consumers more efficiently.

The ribbon-cutting ceremony was attended by Lynn Yeh, CEO, Homart Group; Alfy Zhang, Country Manager for Australia and New Zealand, AliExpress; Martin Ferreyra from Austrade; and Ben Lazzaro, CEO, Australian Made.

From left to right: Ms. Lynn Yeh, CEO, Homart Group; Mr. Ben Lazzaro, CEO, Australian Made; Mr. Martin Ferreyra, Representative, Austrade; and Ms. Alfy Zhang, Country Manager for Australia and New Zealand, AliExpress.

Under the MOU, AliExpress will assist Homart in establishing an official flagship store on its platform, co-launching marketing and promotional campaigns, and enhancing customer experience. Homart, in turn, will provide high-quality, Australian-made health products with a stable and reliable supply chain.

The initial rollout will feature brands such as SpringLeaf, TopLife, GrandPawPaw, and CHÉRI, covering about 40 SKUs, with plans to expand to 200 SKUs within three years and reach cumulative sales of AUD 30 million.

As a long-time participant in the CIIE, Homart has witnessed the deepening cooperation between China and Australia in the health industry. Through its new partnerships with China’s leading e-commerce platforms, the company is building an international strategy centered on the Chinese market while advancing toward global expansion.

“CIIE is not just a showcase — it’s a bridge for collaboration,” said Lynn Yeh, CEO of Homart Group. “Through these partnerships, we hope to bring more premium Australian health products to China and the world. Homart will continue to leverage CIIE as a key platform to strengthen cooperation with partners in China and globally, contributing to a more open, innovative, and sustainable global health ecosystem.”